Back

Rationale, design and baseline characteristics of the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) randomized controlled trial

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy, Other HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Mark Ledwidge

STOP-HF Unit, Dublin (Ireland)

12 More presentations in this session

Presentation thumbnail
Doctor J. Fallon (Cleveland, US)
Abstract Slides
Presentation thumbnail
Mr C. Moliner-Abos (Barcelona, ES)
Abstract
Presentation thumbnail
Doctor J. De Almeida (Coimbra, PT)
Abstract
Presentation thumbnail
Doctor S. Del Prado Diaz (Madrid, ES)
Abstract Slides
Presentation thumbnail
Assistant Professor G. Alonso Salinas (Pamplona, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Pharmacology and Pharmacotherapy

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources